Stay updated on Pembrolizumab in 1st Line NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in 1st Line NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab in 1st Line NSCLC Clinical Trial page
- CheckyesterdayChange DetectedA new revision tag 'Revision: v3.6.5' has been added, replacing 'Revision: v3.6.4'. This indicates an updated revision history for the page.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.6.4 replaces the previous Revision: v3.6.3, indicating a recent update to the page’s content or functionality.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedAdded Revision: v3.6.3 and removed Revision: v3.6.2, signaling a new page release. This appears to be a minor metadata/update rather than content changes to the study details.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page shows Revision: v3.6.2, replacing the previous Revision: v3.6.0 tag as part of a platform revision update.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now shows a recruitment status note ('No longer looking for participants') and adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated Intervention/Treatment section and a Revision: v3.6.0. The previous label 'Intervention / Treatment' has been replaced with 'Intervention/Treatment' and the older 'Revision: v3.5.5' tag was removed.SummaryDifference0.3%

- Check65 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, indicating a minor version update for the page. No substantive content or data changes are reflected in this change set.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in 1st Line NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in 1st Line NSCLC Clinical Trial page.